Published in Lancet on October 05, 1974
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest (1975) 3.03
Current practice in prevention of bacterial endocarditis. Br Heart J (1975) 1.78
The "incubation period" of subacute bacterial endocarditis. Yale J Biol Med (1977) 1.18
Editorial: Antibiotic cover for dental extraction. Br Med J (1975) 0.75
Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol (1972) 8.33
Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest (1973) 5.49
Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol (1993) 5.14
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet (1986) 5.05
Recommendations on blood pressure measurement. Br Med J (Clin Res Ed) (1986) 4.97
Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol (1980) 4.28
Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations. Br J Exp Pathol (1972) 4.03
Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest (1985) 3.98
Experimental bacterial endocarditis. IV. Structure and evolution of very early lesions. J Pathol (1975) 3.96
Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. Br J Exp Pathol (1973) 3.79
Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. J Clin Invest (1988) 3.69
Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob Agents Chemother (1986) 3.38
Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ (2000) 3.37
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest (1975) 3.03
The neuroleptic malignant syndrome. Arch Intern Med (1982) 2.98
Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J Clin Invest (1990) 2.91
International health and internal medicine residency training: the Duke University experience. Am J Med (1995) 2.83
Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA (1990) 2.61
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.35
Prevention of Bacterial Endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Infective Endocarditis of the Council on Cardiovascular Disease in the Young. Circulation (1984) 2.33
Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 2.12
Cryptococcemia. Medicine (Baltimore) (1983) 2.10
Opportunistic infections and Kaposi's sarcoma in homosexual men. N Engl J Med (1981) 2.09
Macrophage-mediated fungistasis in vitro: requirements for intracellular and extracellular cytotoxicity. J Immunol (1986) 2.06
Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci. JAMA (1989) 2.03
Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J Antimicrob Chemother (1985) 2.02
Proteinuria with streptokinase. Lancet (1993) 2.01
Chemotherapy of experimental streptococcal endocarditis. II. Synergism between penicillin and streptomycin against penicillin-sensitive streptococci. J Clin Invest (1974) 1.96
Antibiotic tolerance among clinical isolates of bacteria. Antimicrob Agents Chemother (1986) 1.95
Continuous recording of direct arterial pressure and electrocardiogram in unrestricted man. Br Med J (1972) 1.91
Neurotoxicity of human eosinophils. Proc Natl Acad Sci U S A (1979) 1.89
The weight of medical knowledge. N Engl J Med (1978) 1.87
Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A (1981) 1.85
Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells. J Infect Dis (1987) 1.85
Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis. Antimicrob Agents Chemother (1985) 1.78
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304. Antimicrob Agents Chemother (1989) 1.78
Current practice in prevention of bacterial endocarditis. Br Heart J (1975) 1.78
Renal pathological findings in infective endocarditis. Nephrol Dial Transplant (2000) 1.74
Single and multiple pyogenic liver abscesses. Natural history, diagnosis and treatment, with emphasis on percutaneous drainage. Medicine (Baltimore) (1984) 1.68
Median nerve palsy--a complication of brachial artery cannulation. Postgrad Med J (1976) 1.65
Busulphan lung. Thorax (1969) 1.63
Fever of unknown origin--reexamined and redefined. Curr Clin Top Infect Dis (1991) 1.63
Acute aortitis and aortic incompetence due to systemic rheumatological disorders. Int J Cardiol (1991) 1.59
Differential diagnosis of acute meningitis. An analysis of the predictive value of initial observations. JAMA (1989) 1.58
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole. J Infect Dis (1982) 1.58
Protective role of complement in experimental Escherichia coli endocarditis. Infect Immun (1977) 1.57
Chemotherapy of experimental streptococcal endocarditis. 3. Failure of a bacteriostatic agent (tetracycline) in prophylaxis. J Clin Pathol (1974) 1.56
Direct arterial pressure, heart rate and electrocardiogram during human coitus. J Reprod Fertil (1974) 1.56
Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis (1993) 1.55
Influence of once-daily administration of beta-adrenoceptor antagonists on arterial pressure and its variability. Lancet (1979) 1.50
Some aspects of the arterial response to venous occlusion in man. Clin Sci (Lond) (1983) 1.49
Efficacy of ampicillin plus a beta-lactamase inhibitor (CP-45,899) in experimental endocarditis due to Staphylococcus aureus. J Infect Dis (1981) 1.48
Use of opposing reflex stimuli and heart rate variability to examine the effects of lipophilic and hydrophilic beta-blockers on human cardiac vagal control. Clin Sci (Lond) (1999) 1.47
Effect of immunization on susceptibility to experimental Streptococcus mutans and Streptococcus sanguis endocarditis. Infect Immun (1978) 1.44
Mitochondrial iron loss from leukemia cells injured by macrophages. A possible mechanism for electron transport chain defects. J Immunol (1988) 1.41
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci. Antimicrob Agents Chemother (1982) 1.41
Identification of a novel antigen from Staphylococcus epidermidis. FEMS Immunol Med Microbiol (2000) 1.40
Dental prophylaxis for endocarditis. Lancet (1992) 1.39
Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals. Lancet (1988) 1.38
Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure. Circulation (1975) 1.37
Felodipine, blood pressure, and cardiovascular reflexes in hypertensive humans. Hypertension (1986) 1.36
The straight back syndrome. Q J Med (1980) 1.35
Apparent failures of endocarditis prophylaxis. Analysis of 52 cases submitted to a national registry. JAMA (1983) 1.35
Felodipine in hypertension. Eur J Clin Pharmacol (1985) 1.32
Acute myocardial infarction in Asians and whites in Birmingham. Br Med J (Clin Res Ed) (1985) 1.32
Survival after acute myocardial infarction in Asian and white patients in Birmingham. Br Heart J (1995) 1.32
Chemotherapy of experimental streptococcal endocarditis. VI. Prevention of enterococcal endocarditis. J Lab Clin Med (1977) 1.31
Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev Infect Dis (1985) 1.31
Coronary artery disease in Asians in Birmingham. Br Heart J (1984) 1.29
Influence of agglutinating antibody in experimental cryptococcal meningitis. Br J Exp Pathol (1981) 1.29
The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J (2001) 1.29
Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob Agents Chemother (1987) 1.27
Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium. Cardiovasc Res (1980) 1.26
Treatment of experimental disseminated candidiasis with cilofungin. Antimicrob Agents Chemother (1989) 1.26
Critical assessment of diagnostic value of endomyocardial biopsy. Assessment of cardiac biopsy. Br Heart J (1978) 1.26
Acquired pulmonary stenosis. Thorax (1970) 1.26
Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet (1989) 1.25
Eligibility for thrombolytic therapy in acute myocardial infarction. Lancet (1987) 1.25
Why do patients develop reactions to streptokinase? Clin Exp Immunol (1993) 1.23
Direct arterial pressure, heart rate, and electrocardiogram during cigarette smoking in unrestricted patients. Am Heart J (1975) 1.20
Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity. Infect Immun (1988) 1.19
Effects of cyclosporine in experimental cryptococcal meningitis. Infect Immun (1985) 1.19
Manifestations of human T-lymphotropic virus type I infection. Am J Med (1988) 1.19
Influence of racial origin on admission rates of patients with suspected myocardial infarction in Birmingham. Br Heart J (1991) 1.17
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med (1982) 1.16
Cellular immunity in congestive cardiomyopathy. The normal cellular immune response. Br Heart J (1985) 1.15
Oral microflora as a cause of endocarditis and other distant site infections. Infect Dis Clin North Am (1999) 1.14
Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo. Br Heart J (1985) 1.13
Macrophage-mediated fungistasis: requirement for a macromolecular component in serum. J Immunol (1986) 1.12
Uptake of itraconazole by alveolar macrophages. Antimicrob Agents Chemother (1993) 1.12
The effect of nifedipine on arterial pressure and reflex cardiac control. Circulation (1983) 1.10
Evaluation of PCR in the molecular diagnosis of endocarditis. J Infect (2004) 1.09
Direct arterial pressure and electrocardiogram during motor car driving. Br Med J (1973) 1.09
Baroreflex setting and sensitivity after acute and chronic nicardipine therapy. Clin Sci (Lond) (1984) 1.09
Rhodococcus equi causing human pulmonary infection: review of 29 cases. South Med J (1991) 1.07
Gay compromise syndrome. Lancet (1981) 1.07
Therapeutic significance of penicillin tolerance in experimental streptococcal endocarditis. Antimicrob Agents Chemother (1983) 1.06